DGX
Quest Diagnostics Incorporated
246.50$
-0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 16.2% | 15.1% | 15.2% | 12.4% | 12.6% | 19.4% | 21.8% | 20.1% | 14.8% | 16.9% | 14.8% | 14.7% | |
| 1.9% | 1.3% | 3.6% | 1.3% | 1.2% | 9.3% | 8.3% | 6.4% | 2.5% | 4.9% | 3.4% | 2.6% | |
| 1.9% | 1.3% | 3.6% | 1.3% | 1.2% | 9.3% | 8.3% | 6.4% | 2.5% | 4.9% | 3.4% | 2.6% | |
| 9.4% | 9.0% | 9.2% | 8.8% | 9.2% | 8.3% | 10.8% | 10.6% | 9.3% | 8.6% | 8.1% | 8.7% | |
| 1.1% | 0.8% | 0.8% | 0.9% | 0.9% | 1.0% | 1.6% | 1.5% | 1.5% | 1.4% | 1.2% | 1.2% | |
| 9.4% | 9.3% | 10.2% | 10.9% | 11.7% | 11.3% | 11.6% | 16.9% | 18.3% | 17.2% | 17.1% | 17.6% | |
| 61.1% | 59.3% | 59.4% | 60.3% | 59.6% | 51.5% | 49.0% | 52.1% | 56.2% | 55.1% | 54.8% | 55.1% | |
| 10.8% | 9.9% | 9.4% | 10.7% | 11.0% | 8.7% | 8.3% | 8.6% | 8.5% | 8.3% | 10.9% | 10.1% | |
| 56.2% | 52.0% | 53.1% | 52.1% | 51.4% | 55.1% | 50.9% | 51.8% | 53.2% | 54.2% | 57.3% | 55.1% | |
| 17.3% | 11.8% | 9.7% | 10.1% | 13.5% | 15.5% | 12.7% | 12.9% | 12.1% | 12.9% | 13.4% | 14.0% | |
| 5.2% | 1.6% | 0.1% | 1.0% | 5.1% | 8.1% | 2.1% | 2.0% | 1.9% | 4.2% | 5.8% | 4.2% | |
| 2.6% | 2.8% | 2.6% | 2.1% | 2.0% | 2.0% | 3.2% | 2.6% | 2.5% | 2.7% | 1.8% | 9.9% | |
| 32.8% | 35.1% | 36.9% | 35.7% | 31.2% | 30.9% | 28.6% | 29.5% | 31.0% | 31.5% | 34.8% | 31.8% | |
| 43.5% | 47.0% | 45.8% | 46.9% | 47.4% | 43.9% | 48.2% | 47.3% | 45.9% | 45.0% | 42.0% | 44.2% | |
| 57.9% | 62.2% | 65.5% | 68.0% | 69.1% | 63.6% | 66.3% | 56.2% | 64.6% | 62.9% | 57.9% | 61.6% | |
| 1.5% | 1.5% | 1.4% | 1.3% | 1.3% | 1.1% | 1.0% | 0.9% | 0.9% | 0.8% | 0.7% | 0.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.